Literature DB >> 20423678

Adult mesenchymal stem cells: an innovative therapeutic for lung diseases.

Tracey L Bonfield1, Arnold I Caplan.   

Abstract

Adult human mesenchymal stem cells (hMSCs) are the focus of a number of clinical applications. The advantage of hMSCs is that they are immuno-modulatory and versatile due to their secreted bioactive molecules that are anti-inflammatory and regenerative. These cells have the potential to orchestrate reparative processes in diseased or injured tissues. Much of the diversity and uniqueness of hMSCs is defined by their response to the milieu of injured tissue. hMSCs are sensitive to their site-specific microenvironment, and it is anticipated that they will deliver the bioactive agents in a site-specific manner quite different from the way pharmaceutical drugs work. This review highlights current concepts of such functions with a focus on the clinical utility of hMSCs in the treatment of lung diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20423678

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  30 in total

1.  Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model.

Authors:  Maryam Mohammadian; Hamid Reza Sadeghipour; Iraj Ragerdi Kashani; Gila Pirzad Jahromi; Amene Omidi; Amir Kavian Nejad; Ravie Golchoobian; Mohammad Hossein Boskabady
Journal:  Lung       Date:  2016-05-09       Impact factor: 2.584

2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

3.  Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.

Authors:  Miguel J Divo; Carlos Cabrera; Ciro Casanova; Jose M Marin; Victor M Pinto-Plata; Juan P de-Torres; Javier Zulueta; Jorge Zagaceta; Pablo Sanchez-Salcedo; Juan Berto; Claudia Cote; Bartolome R Celli
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

4.  Mesenchymal Stem Cell Soluble Mediators and Cystic Fibrosis.

Authors:  Morgan T Sutton; David Fletcher; Nicole Episalla; Lauren Auster; Sukhmani Kaur; Mary Chandler Gwin; Michael Folz; Dante Velasquez; Varun Roy; Rolf van Heeckeren; Donald P Lennon; Arnold I Caplan; Tracey L Bonfield
Journal:  J Stem Cell Res Ther       Date:  2017-09-22

5.  Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells.

Authors:  Linda Badri; Natalie M Walker; Takashi Ohtsuka; Zhuo Wang; Mario Delmar; Andrew Flint; Marc Peters-Golden; Galen B Toews; David J Pinsky; Paul H Krebsbach; Vibha N Lama
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-04       Impact factor: 6.914

Review 6.  Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain.

Authors:  Ken P Ehrhardt; Susan M Mothersele; Andrew J Brunk; Jeremy B Green; Mark R Jones; Craig B Billeaud; Alan David Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

7.  Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells.

Authors:  Laura Shin; Daniel A Peterson
Journal:  Stem Cells Transl Med       Date:  2012-12-21       Impact factor: 6.940

8.  Enhancing Cystic Fibrosis Immune Regulation.

Authors:  Anna M van Heeckeren; Morgan T Sutton; David R Fletcher; Craig A Hodges; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 9.  Therapeutic applications of mesenchymal stroma cells in pediatric diseases: current aspects and future perspectives.

Authors:  Hamid S Habib; Taher F Halawa; Hazem M Atta
Journal:  Med Sci Monit       Date:  2011-11

Review 10.  Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation.

Authors:  Dimitry A Chistiakov
Journal:  J Biomed Sci       Date:  2010-12-07       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.